Home Alzheimer’s Disease FDA Approves Durvalumab Plus Standard of Care Chemo for Extensive-Stage SCLC

FDA Approves Durvalumab Plus Standard of Care Chemo for Extensive-Stage SCLC

The FDA approved durvalumab (Imfinzi) as a first-line treatment for adult patients with extensive-stage small cell lung cancer (ES-SCLC) in combination with standard-of-care (SOC) chemotherapies, etoposide plus either carboplatin or cisplatin (platinum-etoposide), according to AstraZeneca, the agent’s developer.

The approval was based on positive results from the phase III CASPIAN trial, which found that durvalumab in combination SOC platinum-etoposide demonstrated a statistically significant and clinically meaningful improvement in overall survival (OS), versus SOC alone. 

“The US approval of Imfinzi brings a new medicine to extensive-stage small cell lung cancer patients in urgent need of new options,” Dave Fredrickson, executive vice president of the Oncology Business Unit, said in a press release. “Imfinzi is the only immunotherapy to show both a significant survival…

Continue Reading to the Source

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Parasite found in undercooked meat linked with risk of rare brain cancer

submitted by /u/Meat_Mithkabob Continue Reading to the Source

Living up to expectations : braincancer

Hey everyone!I wrote a little something about some of the comments you often hear from others and how sometimes you feel like you need...

My Brain Tumor Taught Me To Shift My Perspective on These 5 Things

submitted by /u/andrewjoegeorge Continue Reading to the Source

Recent Comments